Chinese Herbal Medicine Yindan Xinnaotong Soft Capsules
Yindan Xinnaotong Soft Capsules are produced with Chinese herbs and applications are Chest bi disorder due to qi stagnation and blood stasis, manifested as oppression in the chest, shortness of breath, and palpitations; Angina pectoris in coronary heart disease, hyperlipidaemia，cerebral arteriosclerosis, stroke and sequela of apoplexy with the symptoms described above.
●National medical insurance medicine: In 2005, it has been included in the National basic medical insurance and industrial injury insurance drugs Product Catalog “, but also included in the 2022 edition of the “National Medical Insurance Catalog” Chinese patent medicine part, It is a Class B medical insurance drug for activating qi and blood circulation agents, drug code ZA12B, No. 511.
●National Essential medicine: It has been included in the national Essential medicine list since 2012 and is now also included in 2018 The Chinese patent medicine part of the National Essential Drugs Catalogue is a blood stasis removing agent, which has the function of promoting blood circulation and removing blood stasis Of the effect.
●National Pharmacopoeia: The 2015 edition and the 2020 edition are included.
Treating Heart and Brain Pure Chinese medicine preparation
We Exclusive Miao medicine Yindan Xinnaotong Soft Capsules are produced with Ginkgo Leaf, Danshen Root, Shortscape Fleabane Herb, Gynoacemmae Herba, ,Hawthorn Frui,Garlic Bulb, Sanch, l-Borneol，as a medicines commonly used by the Miao ethnic group, it has actions to activate blood, resolve stasis, move qi, relieve pain, promote digestion and resolve stagnation.Chest bi disorder due to qi stagnation and blood stasis, manifested as oppression in the chest, shortness of breath, and palpitations; Angina pectoris in coronary heart disease, hyperlipidaemia，cerebral arteriosclerosis, stroke and sequela of apoplexy with the symptoms described above.Its clinical application published 8 SCI literature, 8 meta-analysis.
| No. | Journal title | Article title | Publication time | DOI |
| 1 | Heart | Effect of Yindan Xinnaotong capsule on serum IL-6 of patients suffering from unstable angina pectoris |
August 2013 | http://dx.doi.org/10.1136/heartjnl-2013-304613.407 |
| 2 | BMC complementary and altern ative medicine |
Prevention of atherosclerosis by Yindan Xinnaotong capsule combined with swimming in rats |
8 April 2015 | 10.1186/s12906-015-0622-7 |
| 3 | Scientific Reports | Yindanxinnaotong, a Chinese compound medicine, synergistically attenuates atherosclerosis progress |
21 July 2015 | 10.1038/srep12333 |
| 4 | Journal of separation science | Identification and evaluation of the chemical similarity of Yindan xinnaotong samples by ultra high performance liquid chromatography with quadrupole time-of-flight mass spectrometry fingerprinting |
4 December 2015 | 10.1002/jssc.201500836 |
| 5 | Hindawi Evidence-based complementary and alternative medicine |
The Clinical Efficacy of Yindanxinnaotong Soft Capsule in the Treatment of Stroke and Angina Pectoris: A Meta-Analysis |
30 April 2017 | https://doi.org/10.1155/2017/2060549 |
| 6 | RSC Advances | Identification of absorbed constituents and evaluation of the pharmacokinetics of main compounds after oral administration of yindanxinnaotong by UPLC-Q- TOF-MS and UPLC-QqQ-MS |
26 April 2018 | 10.1039/c7ra12659j |
| 7 | Journal of Chromatography A | Comprehensive chemical profiling of Yindan Xinnaotong soft capsuleand its neuroprotective activity evaluation in vitro |
Available online 14 May 2019 | https://doi.org/10.1016/j.chroma.2019.05.023 |
| 8 | Phytomedicine | An image-based fingerprint- efficacy screening strategy for uncoveringactive compounds with interactive effects in Yindan Xinnaotong soft capsule |
Available online26 December 2021 | https://doi.org/10.1016/j.phymed.2021.153911 |
Brief Instructions for Yindan Xinnaotong Soft Capsules
[Drug name] Yindan Xinnaotong Soft Capsules
[Approval number] NMPN(national medicine permission number) Z20027144
[Manufacturer] Guizhou Bailing Group Pharmaceutical Co., Ltd
[Functions indications]To activate blood, resolve stasis, move qi, relieve pain, promote digestion and resolve stagnation.Chest bi disorder due to qi stagnation and blood stasis, manifested as oppression in the chest, shortness of breath, and palpitations; Angina pectoris in coronary heart disease, hyperlipidaemia，cerebral arteriosclerosis, stroke and sequela of apoplexy with the symptoms described above.
[Specification] 4g per capsule
[Usage & dosage] Oral, 2-4 capsules per time, three times a day.
[Contraindication] Allergy to this product and its ingredients is prohibited.
FAQ
Related Products
Related News
The company currently owns over 200,000 mu (approximately 30,000 hectares) of medicinal herb cultivation bases, with an extraction capacity of […]
Hi, I’m the author of this post,with more than 20 years of experience in the production and manufacturing of proprietary […]
Beletalent(ZHUHAI)Pharmaceutical Co., Ltd（hereinafter referred to as Beletalent），which was founded in 2023, with a registered capital of 20 million RMB and […]
On the afternoon of January 30, 2024, the first meeting of the first council of the Hengqin Guangdong-Macao Deep Cooperation […]
